Useful in which patients?BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39297.457014.1F (Published 09 August 2007) Cite this as: BMJ 2007;335:271
- Andrew Moore, editor, Bandolier,
- Sheena Derry, senior research associate,
- Grace McGeogh, medical student
- Pain Research, Nuffield Department of Anaesthetics, University of Oxford, The Churchill, Oxford OX3 7LJ
The conclusion of the randomised trial reported by Farmer et al1 is in line with a recent systematic review of randomised trials (1000 patients, three trials) and observational studies (60 000 patients, 13 studies),2 which shows that only when the average starting HbA1c is above 8% do studies consistently show benefit of self monitoring.
The inference that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial